Identification of antigenic determinants of the polar immune response in le
prosy may illuminate both protection and pathogenesis, Thirty subjects Were
studied (22 with polar disease and 8 healthy controls who were heavily exp
osed but disease-free) by assaying the proliferative, interferon (IFN)-gamm
a, and antibody responses to recombinant antigens of Mycobacterium leprae (
10, 28, 36, and 65 kDa). The 10-kDa antigen elicited IFN-gamma production f
rom all tuberculoid (TT) and borderline tuberculoid (BT) patients but littl
e from controls, lepromatous (LL), or borderline lepromatous (BL) patients
(P < .05). Production of 65-kDa-specific IFN-gamma was higher in TT/BT than
in controls or LL/BL patients (P < .906). All subjects produced 65-kDa-spe
cific antibody, but it was higher in TT/BT patients than in healthy control
s, whose responses were higher than in TT/BT subjects (P = .035). The 36-kD
a antibody responses were selectively increased in LL/BL subjects:(P < .02)
. The intermediate phenotype of the controls suggests that M. leprae-specif
ic production of IFN-gamma may contribute to pathology and to protection in
leprosy.